CRKL and prostate carcinoma: As Runx2 has been implicated in RANKL expression in various cell types, such as prostate cancer cells, vascular smooth muscle cells, and osteoblasts [49,50,51,52], we further examined whether CrkL-inhibited Tnfsf11 expression is involved in the regulation of Runx2 expression.